Nancy Halnon
Pediatric Cardiology · Los Angeles, CANPI 1215983614
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (43.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Pfizer at 43.3% of the total. Reporting peaked in 2024 at $4,026 and has fallen 99.5% since, to $21 in 2025.
Across 31 payments — averaging $200.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$3K
- Actelion Pharmaceuticals, Ltd$1K
- Merck$1K
- NS Pharma, Inc.$588
- Sarepta Therapeutics, Inc.$184
- Actelion Pharmaceuticals US, Inc.$125
- plus $145 from 5 others
Across 26 payments — averaging $19,353 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$302K
- Merck$140K
- Cumberland Pharmaceuticals, Inc.$61K
What the payments were for
- Consulting fees$2,70043%
- Speaking & faculty fees$5008%
- Travel & lodging$2,12334%
- Food & beverage$90715%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 1 | $2,700 |
| Actelion Pharmaceuticals, Ltd | 6 | $1,269 |
| Merck | 8 | $1,219 |
| NS Pharma, Inc. | 5 | $588 |
| Sarepta Therapeutics, Inc. | 4 | $184 |
| Actelion Pharmaceuticals US, Inc. | 1 | $125 |
| Abbott | 2 | $48 |
| Abiomed | 1 | $40 |
| ITF Therapeutics LLC | 1 | $21 |
| Biogen | 1 | $20 |
| Sobi, Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UPTRAVI$1,274
- VERQUVO$877
- OPSUMIT$125
- Exondys 51$115
How this compares
$6,229 in reported general payments places this provider in the 85th percentile of 239 pediatric cardiology providers in California.
Other pediatric cardiology in Los Angeles
- Daniel LeviLos Angeles$914K
- John WoodLos Angeles$122K
- Leigh ReardonLos Angeles$87K
- Pierre WongLos Angeles$38K
- Stephen NageotteLos Angeles$36K
- Mark SklanskyLos Angeles$23K
- Ruchira GargLos Angeles$16K
- Juan AlejosLos Angeles$15K
- Kevin ShannonLos Angeles$11K
- Claire NewlonLos Angeles$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.